PPARG is a tumor suppressor in basal bladder tumors offering new potential therapeutic opportunities.
Coutos-Thevenot, L.; Beji, S.; Neyret-Kahn, H.; Pippo, Q.; Fontugne, J.; Osz, J.; Krucker, C.; Dos Santos Groeneveld, C.; Dufour, F.; Kamoun, A.; Ley, M.; Chapeaublanc, E.; De Reynies, A.; Lebret, T.; Allory, Y.; Cianferani, S.; Radvanyi, F.; Rochel, N.; BERNARD-PIERROT, I.
Show abstract
PPAR{gamma} activation is a critical event in luminal muscle-invasive bladder cancer (MIBC) tumorigenesis, favoring both tumor cell growth and microenvironment modulation toward tumor immune escape. Conversely, the down-regulation of PPAR{gamma} activity in basal MIBC suggests tumor suppressive effects in this subgroup. Here, we report genetic, epigenetic and functional evidence to support the tumor suppressor role for PPAR{gamma} in basal bladder tumors. We identified hemizygous deletions, DNA hyper-methylation and loss-of-function mutations of PPAR{gamma} in basal MIBC, associated with PPAR{gamma} under-expression and its decreased activity. Re-expression of PPAR{gamma} in basal tumor cells resulted in the activation of PPAR{gamma} -dependent transcription program that modulated fatty acid metabolism and cell differentiation and decreased cell growth, which could partly rely on EGFR down-regulation. Structure-function studies of two PPAR{gamma} mutant revealed a destabilization of a region important for coactivator recruitment and should help develop potent molecules to activate PPAR{gamma} as a therapeutic strategy for basal MIBC. The identification of this subtype-dependent dual role of PPAR{gamma} in MIBC strengthens the critical role of PPAR{gamma} in bladder tumorigenesis and reinforces the interest in stratified medicine based on tumor molecular subtyping. One sentence summaryGenetic, epigenetic and functional evidence of a tumor suppressor role for PPAR{gamma} in basal bladder tumors offer new therapeutic opportunities for this subgroup.
Matching journals
The top 12 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- ERK2-topoisomerase II regulatory axis is important for gene activation in immediate early genes 94%
- Constitutive activity of an atypical chemokine receptor revealed by inverse agonistic nanobodies 94%
- Ligand efficacy shifts a nuclear receptor conformational ensemble between transcriptionally active and repressive states 93%
Similar papers in this journal
- MAGI1 inhibits the AMOTL2/p38 stress pathway and prevents luminal breast tumorigenesis 94%
- The most common RNF43 mutant G659Vfs41 is fully functional in inhibiting Wnt signaling and unlikely to play a role in tumorigenesis 94%
- Selective Impact of ALK and MELK Inhibition on ERα Stability and Cell Proliferation in Cell Lines Representing Distinct Molecular Phenotypes of Breast Cancer 94%
Similar papers in this journal
- Isoform-specific characterization implicates alternative splicing in APOBEC3B as a mechanism restricting APOBEC-mediated mutagenesis 94%
- FLI1 and FRA1 transcription factors drive the transcriptional regulatory networks characterizing muscle invasive bladder cancer 93%
- In-cell proximity target validation methods for heterobifunctional molecules with CRBN- or VHL-binder using AirID 92%
Similar papers in this journal
- AGTR1 is overexpressed in neuroendocrine neoplasms, regulates secretion and may serve as a target for molecular imaging and therapy 93%
- PRMT1 regulates EGFR and Wnt signaling pathways and is a promising target for combinatorial treatment of breast cancer 93%
- Genome-wide CRISPR screen identifies KEAP1 perturbation as a vulnerability of ARID1A-deficient cells 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.